Subsidy for Dutch tuberculosis research
The St Radboud hospital in Nijmegen has received a EUR nine-million subsidy from the EU for research into the prevention of tuberculosis in Africa.Nijmegen - The St Radboud hospital in Nijmegen has received a nine-million euro subsidy from the EU for research into the prevention of tuberculosis in Africa. The scientists are going to research the effect of a higher dose of the drug Rifampicin on tuberculosis patients.
Tuberculosis is a difficult disease to deal with as many patients in developing countries stop taking their medicine too soon. Many of them are afraid of the side effects or no longer feel sick and presume they are better again. The combination of tuberculosis and HIV, which often occurs in Africa, also causes the drugs to be less effective.
The EU has allocated a budget of EUR 27 million for the prevention of tuberculosis in Africa.
An estimated 14 million people all over the world suffer from the lung disease. Every year around one and a half million people die from tuberculosis.
Radio Netherlands / Expatica